Hemoglobin and Iron Metabolism Practice Questions

Q: Which of the following is not classified as a cutaneous porphyria?

Sideroblastic anemia. ***Hereditary coproporphyria*** - This condition is primarily associated with **acute episodes** and **neuropathy**, rather than cutaneous manifestations. [2] - Unlike cutaneous porphyrias, symptoms are more systemic and do not commonly present with **skin lesions**. Although skin features can occur in some instances, they mimic porphyria cutanea tarda. [2] *Congenital erythropoeitic porphyria* - Characterized by severe **cutaneous symptoms** such as blistering and photosensitivity due to **skin exposure**. - Patients exhibit notable **facial disfigurement** and can have **hemolytic anemia**, aligning it clearly with the cutaneous forms of porphyria. *Sideroblastic anemia* - This condition involves issues with **hemoglobin synthesis** and does not fit the porphyria classification. [1] - It primarily presents with **microcytic anemia**, and the symptoms are primarily hematological, not cutaneous. [1] *Erythropoeitic porphyria* - Characterized by **severe photosensitivity** and skin manifestations, similar to congenital erythropoeitic porphyria. [1] - Patients may develop **blisters** and **hyperpigmentation** upon sun exposure, categorizing it among cutaneous porphyrias. [2]

Q: Which porphyrin forms the organic component of heme?

Protoporphyrin IX. ***Protoporphyrin IX*** - **Heme** is formed by the insertion of an **iron atom (Fe2+)** into the center of **protoporphyrin IX**. - **Protoporphyrin IX** is the immediate precursor to heme in the **heme synthesis pathway**. *Uroporphyrin* - **Uroporphyrin** is an earlier precursor in the **heme synthesis pathway** and is much more hydrophilic than protoporphyrin. - It accumulates in diseases like **congenital erythropoietic porphyria (CEP)**, leading to photosensitivity. *Coproporphyrin* - **Coproporphyrin** is an intermediate in the **heme synthesis pathway**, formed after uroporphyrinogen. - It is also more water-soluble than protoporphyrin and its accumulation can be seen in various porphyrias. *Deuteroporphyrin* - **Deuteroporphyrin** is a synthetic porphyrin or a less common natural porphyrin that is not directly involved as the organic component of heme in mammals. - While it is structurally similar to protoporphyrin, it does not serve as the direct precursor for heme formation in the human body.

Q: What is the normal range of ferritin levels in adult males?

30-300 ng/ml. ***30-300 ng/ml*** - The normal range for **ferritin levels** in adult males is typically **30-300 ng/ml** (some laboratories report 30-400 ng/ml). - Ferritin is an **iron storage protein**, and its levels reflect the body's iron stores. - Values below 30 ng/ml suggest **iron deficiency**, while values above 300 ng/ml may indicate iron overload or inflammatory conditions. *10-20 ng/ml* - These levels are **significantly low** and indicate **iron deficiency**. - This range is well below the normal threshold and would warrant investigation and likely iron supplementation. - Levels below 15 ng/ml are diagnostic of **iron deficiency** even in the absence of anemia. *300-500 ng/ml* - Levels in this range are considered **elevated** and can indicate iron overload, chronic inflammation, liver disease, or malignancy. - While some laboratories extend the upper limit to 400 ng/ml, persistent elevation above 300 ng/ml warrants further investigation. - Common causes include **hemochromatosis**, **chronic liver disease**, or **inflammatory conditions**. *500-700 ng/ml* - These levels are **significantly elevated** and strongly suggest **iron overload conditions** such as **hemochromatosis**, severe inflammatory states, or hepatocellular injury. - High ferritin levels can be associated with organ damage, leading to conditions like **cirrhosis** or **cardiomyopathy**. - Requires urgent investigation to identify the underlying cause.

Q: Acute intermittent porphyria is due to deficiency of?

Porphobilinogen deaminase. ***Porphobilinogen deaminase*** - **Acute intermittent porphyria (AIP)** results from a deficiency in **porphobilinogen deaminase** (also known as hydroxymethylbilane synthase). - This enzyme deficiency leads to the accumulation of **aminolevulinic acid (ALA)** and **porphobilinogen (PBG)**, which are neurotoxic and cause the characteristic symptoms of AIP. *Uroporphyrinogen III synthase* - A deficiency in **uroporphyrinogen III synthase** causes **congenital erythropoietic porphyria (Günther disease)**, which is characterized by severe photosensitivity and hemolytic anemia. - This enzyme defect leads to the accumulation of uroporphyrinogen I and coproporphyrinogen I, not the ALA and PBG associated with AIP. *Ferrochelatase* - Deficiency in **ferrochelatase** causes **erythropoietic protoporphyria (EPP)**, which presents with photosensitivity and chronic liver disease due to the accumulation of **protoporphyrin**. - This condition does not cause the acute neurological attacks seen in AIP. *ALA synthase* - **ALA synthase** is the **rate-limiting enzyme** in heme synthesis; while its activity is crucial, a congenital *deficiency* is not the cause of AIP. - Instead, the *upregulation* of ALA synthase activity in AIP (due to the PBG deaminase block) contributes to the accumulation of ALA and PBG.

Q: The primary defect which leads to sickle cell anemia is:

Replacement of glutamate by valine in β-chain of HbA. ***Replacement of glutamate by valine in β-chain of HbA*** - The primary defect in sickle cell anemia is a **point mutation** that leads to the replacement of **glutamic acid** with **valine** in the **sixth position** of the β-globin chain [1]. - This mutation causes the hemoglobin (HbS) to polymerize under low oxygen conditions, resulting in the characteristic **sickle-shaped red blood cells** [1]. *A nonsence mutation in the I3-chain of HbA* - A nonsense mutation leads to a **premature stop codon**, which is not the mechanism behind sickle cell anemia. - This mutation does not involve the β-globin chain, which is critical in this specific disorder. *Substitution of valine by glutamate in the a-chain of HbA* - This statement is incorrect as sickle cell anemia specifically involves the **β-chain**, not the **α-chain**. - Substituting valine with glutamate does not cause sickling but rather the opposite of the actual defect observed in this condition. *An abnormality in porphyrin part of hemoglobin* - Sickle cell anemia does not arise from **porphyrin metabolism issues**, which are related to conditions like **porphyrias**. - The primary defect is a change in the amino acid sequence, not in the porphyrin structure of hemoglobin. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 598-599.

Q: In sickle cell anemia, the mutation at codon 6 results in the substitution of which amino acid?

Valine for glutamic acid. ***Valine for glutamic acid*** - In **sickle cell anemia**, the normal **glutamic acid** at codon 6 of the $\beta$-globin chain is replaced by **valine**. - This single amino acid substitution is responsible for the abnormal **hemoglobin S (HbS)** and the characteristic sickling of red blood cells. *Isoleucine for valine* - This substitution is **not characteristic** of sickle cell anemia. - While other hemoglobinopathies exist, this specific change does not lead to the sickle cell phenotype. *Valine for isoleucine* - This substitution is **not the primary genetic defect** found in sickle cell anemia. - The mutation in sickle cell anemia involves the replacement of a negatively charged amino acid with a neutral one. *Glutamic acid for valine* - This represents the **reverse substitution** of what occurs in sickle cell anemia. - In sickle cell, valine replaces glutamic acid, not the other way around.

Q: What is the rate-limiting enzyme in heme synthesis?

ALA synthase. ***ALA synthase*** - **Aminolevulinate synthase** (ALA synthase) is the first and **rate-limiting enzyme** in the heme synthesis pathway. - Its activity is tightly regulated, and its overexpression or deficiency can lead to disorders like **acute intermittent porphyria**. *Hmg coa reductase* - **HMG-CoA reductase** is the **rate-limiting enzyme** in the **cholesterol biosynthesis pathway**, not heme synthesis. - It is the target enzyme for statin medications, which lower cholesterol levels. *ALA dehydratase* - **ALA dehydratase** (also known as porphobilinogen synthase) is the second enzyme in the heme synthesis pathway, responsible for converting two molecules of **ALA to porphobilinogen**. - While critical, it is not the rate-limiting step; inhibition of this enzyme can lead to **lead poisoning**. *Uroporphyrinogen 1 synthase* - **Uroporphyrinogen I synthase** (also called hydroxymethylbilane synthase or porphobilinogen deaminase) catalyzes the formation of **hydroxymethylbilane** from four molecules of **porphobilinogen**. - A deficiency in this enzyme is associated with **acute intermittent porphyria**, but it is not the rate-limiting enzyme of the overall pathway.

Q: Enzyme defect in acute intermittent porphyria is

Hydroxymethylbilane synthase. ***Hydroxymethylbilane synthase*** - **Acute intermittent porphyria (AIP)** results from a deficiency of **hydroxymethylbilane synthase** (also known as porphobilinogen deaminase or PBG deaminase), which is the third enzyme in the heme synthesis pathway. - This enzyme defect leads to an accumulation of neurotoxic heme precursors, **aminolevulinic acid (ALA)** and **porphobilinogen (PBG)**. *Aminolevulinic acid dehydratase* - A deficiency in **aminolevulinic acid dehydratase (ALA dehydratase)** causes **ALA dehydratase deficiency porphyria (ADP)**, a very rare form of porphyria. - This is distinct from AIP, which involves a defect further down the pathway, leading to different precursor accumulation patterns. *Uroporphyrinogen III synthase* - A defect in **uroporphyrinogen III synthase** causes **congenital erythropoietic porphyria (CEP)**, also known as Günther's disease. - This condition is characterized by severe photosensitivity, hemolytic anemia, and red urine, which are not features of AIP. *Uroporphyrinogen decarboxylase* - A deficiency in **uroporphyrinogen decarboxylase (UROD)** is the cause of **porphyria cutanea tarda (PCT)**. - PCT is the most common porphyria and primarily presents with blistering skin lesions and increased iron levels, not acute neurovisceral attacks as seen in AIP.

Q: In the context of human hemoglobin function, which of the following factors is most critical to be conserved among its variants?

Ligand binding residues. **Ligand binding residues** - The **ligand binding residues** within the heme pocket are crucial for hemoglobin's primary function of reversible oxygen binding and transport. - Even minor alterations in these critical residues can severely impair oxygen affinity and delivery, leading to clinical conditions such as **hemoglobinopathies**. *Amino acid sequence* - While the overall amino acid sequence is important for protein structure, variations can exist (e.g., in different hemoglobin subunits or species) without compromising function. - Certain amino acid substitutions, especially those not at the active site, might be tolerated or even beneficial. *Overall protein structure* - The overall **quaternary and tertiary structure** is vital for cooperativity and allosteric regulation but is often robust to minor sequence changes. - Maintenance of the 3D structure is a consequence of the sequence, but direct conservation of the entire structure is less critical than the active site. *Environmental factors* - Environmental factors such as pH, temperature, and 2,3-BPG concentration **modulate** hemoglobin function but are not intrinsic parts of the hemoglobin molecule itself. - While important for physiological regulation, they are external influences rather than conserved structural elements within the protein.

Question 1

Which of the following is not classified as a cutaneous porphyria?

Accepted Answer

Sideroblastic anemia

Answer

Congenital erythropoietic porphyria

Answer

Erythropoietic protoporphyria

Answer

Hereditary coproporphyria

Question 2

Which of the following statements about hemoglobin is true?

Accepted Answer

Hemoglobin consists of two alpha and two beta subunits, each capable of binding one O2 molecule.

Answer

Each hemoglobin molecule can bind up to six O2 molecules.

Answer

Each hemoglobin subunit contains two heme groups, which bind oxygen.

Answer

Each hemoglobin molecule is made of 6 polypeptide chains.

Question 3

Which porphyrin forms the organic component of heme?

Accepted Answer

Protoporphyrin IX

Answer

Uroporphyrin

Answer

Coproporphyrin

Answer

Deuteroporphyrin

Question 4

What is the normal range of ferritin levels in adult males?

Accepted Answer

30-300 ng/ml

Answer

300-500 ng/ml

Answer

10-20 ng/ml

Answer

500-700 ng/ml

Question 5

Acute intermittent porphyria is due to deficiency of?

Accepted Answer

Porphobilinogen deaminase

Answer

Uroporphyrinogen III synthase

Answer

Ferrochelatase

Answer

ALA synthase

Question 6

The primary defect which leads to sickle cell anemia is:

Accepted Answer

Replacement of glutamate by valine in β-chain of HbA

Answer

An abnormality in porphyrin part of hemoglobin

Answer

A nonsense mutation in the β-chain of HbA

Answer

Substitution of valine by glutamate in the α-chain of HbA

Question 7

In sickle cell anemia, the mutation at codon 6 results in the substitution of which amino acid?

Accepted Answer

Valine for glutamic acid

Answer

Isoleucine for valine

Answer

Valine for isoleucine

Answer

Glutamic acid for valine

Question 8

What is the rate-limiting enzyme in heme synthesis?

Accepted Answer

ALA synthase

Answer

HMG CoA reductase

Answer

ALA dehydratase

Answer

Uroporphyrinogen 1 synthase

Question 9

Enzyme defect in acute intermittent porphyria is

Accepted Answer

Hydroxymethylbilane synthase

Answer

Aminolevulinic acid dehydratase

Answer

Uroporphyrinogen decarboxylase

Answer

Uroporphyrinogen III synthase

Question 10

In the context of human hemoglobin function, which of the following factors is most critical to be conserved among its variants?

Accepted Answer

Ligand binding residues

Answer

Amino acid sequence

Answer

Overall protein structure

Answer

Environmental factors

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?